111 results on '"Reyes-Sandoval, Arturo"'
Search Results
2. List of contributors
3. Viral-vectored vaccines against SARS-CoV-2
4. Convergent trends and spatiotemporal patterns of Aedes-borne arboviruses in Mexico and Central America
5. Optimization of Small-Scale Production of Zika Virus Envelope Glycoprotein by Transient Expression in HEK293 Cells for ELISA
6. Production and Purification of Zika Virus NS1 Glycoprotein in HEK293 Cells
7. Protein-based Nanoparticle Vaccine Approaches Against Infectious Diseases
8. Convergent trends and spatiotemporal patterns of arboviruses in Mexico and Central America
9. Plasmodium vivax MSP1-42 kD Variant Proteins Detected Naturally Induced IgG Antibodies in Patients Regardless of the Infecting Parasite Phenotype in Mesoamerica
10. Chikungunya Virus: Priority Pathogen or Passing Trend?
11. Recent Developments in Vaccines against Flaviviruses and Alphaviruses
12. Parameters to Predict the Outcome of Severe and Critical COVID-19 Patients when Admitted to the Hospital
13. Author Reply to Peer Reviews of Low immunogenicity of malaria pre-erythrocytic stages can be overcome by vaccination
14. Dengue Vaccines: An Update
15. Development of Viral-Vectored Vaccines and Virus Replicon Particle-Based Neutralisation Assay against Mayaro Virus
16. Cutting Edge: Subunit Booster Vaccination Confers Sterilizing Immunity against Liver-Stage Malaria in Mice Initially Primed with a Weight-Normalized Dose of Radiation-Attenuated Sporozoites
17. Platelet activation and aggregation response to dengue virus nonstructural protein 1 and domains
18. Plasmodium vivax pre-erythrocytic vaccines
19. A universal vaccine candidate against Plasmodium vivax malaria confers protective immunity against the three PvCSP alleles
20. Development of Zika NS1 ELISA methodology for seroprevalence detection in a cohort of Mexican patients in an endemic region
21. Temperature-dependent secretion of Zika virus envelope and non-structural protein 1 in mammalian cells for clinical applications
22. A single dose of ChAdOx1 Chik vaccine induces neutralizing antibodies against four chikungunya virus lineages in a phase 1 clinical trial
23. Dissection-independent production of Plasmodium sporozoites from whole mosquitoes
24. Dengue Virus Induces the Expression and Release of Endocan from Endothelial Cells by an NS1–TLR4-Dependent Mechanism
25. Re-thinking yellow fever vaccines: fighting old foes with new generation vaccines
26. A VLP for validation of the Plasmodium falciparum circumsporozoite protein junctional epitope for vaccine development
27. Low immunogenicity of malaria pre‐erythrocytic stages can be overcome by vaccination
28. Generation of a Genetically Modified Chimeric Plasmodium falciparum Parasite Expressing Plasmodium vivax Circumsporozoite Protein for Malaria Vaccine Development
29. SARS-CoV-2 mutations and where to find them: an in silico perspective of structural changes and antigenicity of the spike protein
30. Adenoviral-Vectored Mayaro and Chikungunya Virus Vaccine Candidates Afford Partial Cross-Protection From Lethal Challenge in A129 Mouse Model
31. A bioinformatic prediction of antigen presentation from SARS‐CoV‐2 spike protein revealed a theoretical correlation of HLA‐DRB1*01 with COVID‐19 fatality in Mexican population: An ecological approach
32. Discovery of four new B-cell protective epitopes for malaria using Q beta virus-like particle as platform
33. Importance of the Immunodominant CD8 + T Cell Epitope of Plasmodium berghei Circumsporozoite Protein in Parasite- and Vaccine-Induced Protection
34. Low immunogenicity of malaria pre-erythrocytic stages can be overcome by vaccination
35. Chikungunya E2 Protein Produced in E. coli and HEK293-T Cells—Comparison of Their Performances in ELISA
36. Recombinant Plasmodium vivax circumsporozoite surface protein allelic variants: antibody recognition by individuals from three communities in the Brazilian Amazon
37. Evaluation of Chimpanzee Adenovirus and MVA Expressing TRAP and CSP from Plasmodium cynomolgi to Prevent Malaria Relapse in Nonhuman Primates
38. Balanced immunity is key for a successful dengue vaccine
39. Sero-prevalence of arthropod-borne viral infections among Lukanga swamp residents in Zambia
40. Dissection-independent production of a protective whole-sporozoite malaria vaccine
41. Immunogenicity and Efficacy of Zika Virus Envelope Domain III in DNA, Protein, and ChAdOx1 Adenoviral-Vectored Vaccines
42. Protective efficacy of peptides from Plasmodium vivax circumsporozoite protein
43. SARS-CoV-2 mutations and where to find them: An in silico perspective of structural changes and antigenicity of the Spike protein
44. COVID-19 vaccines: breaking record times to first-in-human trials
45. Drug-cured experimental Trypanosoma cruzi infections confer long-lasting and cross-strain protection
46. The importance of the immunodominant CD8+ T cell epitope ofPlasmodium bergheicircumsporozoite protein in parasite- and vaccine-induced protection
47. Conservation of the OmpC Porin Among Typhoidal and Non-Typhoidal Salmonella Serovars
48. A multi-genotype therapeutic human papillomavirus vaccine elicits potent T cell responses to conserved regions of early proteins
49. Considering Genomic and Immunological Correlates of Protection for a Dengue Intervention
50. A Single and Un-Adjuvanted Dose of a Chimpanzee Adenovirus-Vectored Vaccine against Chikungunya Virus Fully Protects Mice from Lethal Disease
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.